Inspections, Compliance, Enforcement, and Criminal Investigations
Spa 35 - Close Out letter 5/21/10
|
Public Health Service Food and Drug Administration |
| Silver Spring, MD 20993 |
May 21, 2010
Mr. Warren Danforth, Owner
Spa 35
403 S. 11th Street, Suite 135
Boise, ID 83702
Dear Mr. Danforth:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter dated April 5, 2010. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA follow-up and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Michael M. Levy, Jr., Esq.
Director
Division of New Drugs & Labeling Compliance
Office of Compliance
Center for Drug Evaluation and Research





Department of Health and Human Services

